Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lesinurad Monotherapy Long-Term Extension in Gout
NCT01650246Phase 3Completed
- Sponsor
- Ardea Biosciences, Inc.
- Start
- Aug 2012
- Primary completion
- Apr 2014
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 3 trial of lesinurad in gout, sponsored by Ardea Biosciences, Inc.. Started Aug 2012; status: completed.
02
Drugs
lesinurad
03
Conditions
gout
Beyond the preview
Go deeper on NCT01650246.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01650246.